SAB Biotherapeutics, Inc. (SABSW)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous Close | 0.0300 |
| Open | 0.0410 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0303 - 0.0448 |
| 52 Week Range | 0.0303 - 0.0448 |
| Volume | |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.80 |
| PE Ratio (TTM) | 0.10 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
SAB Biotherapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
SAB Biotherapeutics ( NASDAQ:SABS ) Full Year 2023 Results Key Financial Results Net loss: US$42.2m (loss widened by...
- Simply Wall St.
Individual investors are SAB Biotherapeutics, Inc.'s (NASDAQ:SABS) biggest owners and were rewarded after market cap rose by US$535m last week
Key Insights SAB Biotherapeutics' significant individual investors ownership suggests that the key decisions are...
© 2024 Yahoo. All rights reserved.